Diana Brainard Allovir, Inc. (ALVR) insider trading activity

Diana Brainard is Chief Executive Officer of Allovir, Inc.. Currently has a direct ownership of 723,363 shares of ALVR, which is worth approximately $397,849. The most recent transaction as insider was on Jul 19, 2023, when has been sold 8,342 shares (Common Stock) at a price of $3.56 per share, resulting in proceeds of $29,697. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 723K

4.05% 3M change

17.32% 12M change

Total Value Held $397,849

Diana Brainard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 19 2023	SELL Open market or private sale	$29,697 $3.56 p/Share	8,342 Reduced 0.91%	907,299 Common Stock
Jul 05 2023	SELL Open market or private sale	$16,088 $3.05 p/Share	5,275 Reduced 0.57%	915,641 Common Stock
May 18 2023	SELL Open market or private sale	$19,096 $4.21 p/Share	4,536 Reduced 0.49%	916,628 Common Stock
Apr 19 2023	SELL Open market or private sale	$31,193 $3.71 p/Share	8,408 Reduced 0.9%	921,164 Common Stock
Feb 21 2023	SELL Open market or private sale	$33,958 $6.63 p/Share	5,122 Reduced 0.55%	929,572 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	332,500 Added 26.23%	934,964 Common Stock
Jan 19 2023	SELL Open market or private sale	$174,929 $5.08 p/Share	34,435 Reduced 5.41%	601,607 Common Stock
Nov 18 2022	SELL Open market or private sale	$32,824 $7.27 p/Share	4,515 Reduced 0.71%	633,033 Common Stock
Aug 18 2022	SELL Open market or private sale	$35,417 $7.76 p/Share	4,564 Reduced 0.71%	637,548 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	-	100,000 Added 13.48%	642,112 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	48,125 Added 8.15%	542,112 Common Stock
May 18 2022	SELL Open market or private sale	$126,155 $4.33 p/Share	29,135 Reduced 5.59%	492,165 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	315,000 Added 37.67%	521,300 Common Stock
May 17 2021	BUY Grant, award, or other acquisition	-	200,000 Added 49.22%	206,300 Common Stock

Also insider at

NKTR

NEKTAR THERAPEUTICS Healthcare

Director

Diana Brainard

Chief Executive Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALVR shares.

Notify only if

Value

Insider Trading

Get notified when an Allovir, Inc. insider buys or sells ALVR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Allovir, Inc.

Track Activities on ALVR

Account